Abstract
Interleukin 17 (IL-17) is one of the pro-inflammatory cytokine. Psoriasin is a noticeably over-expressed protein found in the skin lesions of psoriatic patients. Our current study was planned to examine the association of (− 947 A/G) single nucleotide polymorphism (SNP) in IL-17RA promoter region (rs4819554) with psoriasis susceptibility in Egyptian psoriatic patients. Our study included 100 patients and 100, age as well as sex matched, control groups. IL-17RA SNP association was studied using allelic discrimination. RT-qPCR and ELISA were done to assess IL-17 expression. ELISA was performed to assess psoriasin expression. Our study showed a significant association between IL-17 rs4819554 SNP and psoriasis risk, evidenced by higher G allele and AG genotype frequencies in psoriatic patients when compared to controls (allelic: OR 2.283, 95% CI 1.321–3.946, p = 0.003, and genotype: OR 3.026, 95% CI 1.356–6.752, p = 0.007). Additionally, serum psoriasin level was significantly increased when comparing psoriatic patients to controls (p = 0.0003). Moreover, significant increase in IL 17 gene and protein level in AA, AG psoriatic genotypes compared to the corresponding genotypes in normal control (p = 0.0004). IL-17 rs4819554 is significantly associated with psoriasis, and with psoriasin level, in the Egyptian population.
Similar content being viewed by others
References
Batalla A, Coto E, González-Lara L, González-Fernández D, Gómez J, Aranguren TF, Queiro R, Santos-Juanes J, López-Larrea C, Coto-Segura P (2015) (2015) Association between single nucleotide polymorphisms IL17RA rs4819554 and IL17E rs79877597 and Psoriasis in a Spanish cohort. J Dermatol Sci 80(2):111–115
Perera GK, Di Meglio P, Nestle FO (2012) Psoriasis. Annu Rev Pathol 7:385–422
Omar SS, Helaly HA (2018) Prevalence of ocular findings in a sample of Egyptian patients with psoriasis. Indian J Dermatol Venereol Lepr 84(1):34–38
Menter A, Gottlieb A, Feldman SR, Van Voorhees AS, Leonardi CL, Gordon KB, Lebwohl M et al (2008) Guidelines of care for the management of psoriasis and psoriatic arthritis. J Am Acad Dermatol 58:826–850
Griffiths CE, Barker JN (2007) Pathogenesis and clinical features of psoriasis. Lancet 370:263–271
Naldi L (2004) Epidemiology of psoriasis. Curr Drug Targets Inflamm Allergy 3:121–128
Feng BJ, Sun LD, Soltani-Arabshahi R, Bowcock AM, Nair RP, Stuart P, Elder JT, Schrodi SJ, Begovich AB, Abecasis GR, Zhang XJ, Callis-Duffin KP, Krueger GG, Goldgar DE (2009) Multiple loci within the major histocompatibility complex confer risk of psoriasis. PLoS Genet 5(8):e1000606
Rønholt K, Iversen L (2017) Old and new biological therapies for psoriasis. Int J Mol Sci 18(11):2297
Sushanta KS, Abhilasha S, Neha K (2016) Ayurvedic management of psoriasis (EK KUSTHA)—a case study. World J Pharm Res 5(11):1030–1037
Boutet MA, Nerviani A, Gallo Afflitto G, Pitzalis C (2018) Role of the IL-23/IL-17 axis in psoriasis and psoriatic arthritis: the clinical importance of its divergence in skin and joints. Int J Mol Sci 19(2):E530
Blauvelt A, Chiricozzi A (2018) The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis. Clin Rev Allergy Immunol 55(3):379–390
Starnes T, Robertson MJ, Sledge G, Kelich S, Nakshatri H, Broxmeyer HE, Hromas R (2001) Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J Immunol 167(8):4137–4140
Sarkar S, Justa S, Brucks M, Endres J, Fox DA, Zhou X, Alnaimat F et al (2014) Interleukin (IL)-17A, F and AF in inflammation: a study in collagen-induced arthritis and rheumatoid arthritis: IL-17 subtypes in inflammatory arthritis. Clin Exp Immunol 177:652–661
Martin DA, Towne JE, Kricorian G, Klekotka P, Gudjonsson JE, Krueger JG, Russell CB (2013) The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings. J Investig Dermatol 133(1):17–26
Guttman-Yassky E, Lowes MA, Fuentes-Duculan J, Zaba LC, Cardinale I, Nograles KE, Khatcherian A, Novitskaya I, Carucci JA, Bergman R, Krueger JG (2008) Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis. J Immunol 181:7420–7427
Yan N, Yu YL, Yang J, Qin Q, Zhu YF, Wang X, Song RH et al (2012) Association of interleukin-17A and -17F gene single-nucleotide polymorphisms with autoimmune thyroid diseases. Autoimmunity 45:533–539
Jang WC, Nam YH, Ahn YC, Lee SH, Park SH, Choe JY, Lee SS et al (2008) Interleukin-17F gene polymorphisms in Korean patients with Behçet's disease. Rheumatol Int 29:173–178
Lew BL, Cho HR, Haw S, Kim HJ, Chung JH, Sim WY (2012) Association between IL17A/IL17RA gene polymorphisms and susceptibility to alopecia areata in the Korean Population. Ann Dermatol 24:61–65
Corrêa JD, Madeira MF, Resende RG, Correia-Silva Jde F, Gomez RS, de Souza DG, Teixeira MM, Queiroz-Junior CM, da Silva TA (2012) Association between polymorphisms in interleukin-17A and -17F genes and chronic periodontal disease. Mediators Inflamm 2012:846052
Peng R, Yue J, Han M, Zhao Y, Liu L, Liang L (2013) The IL-17F sequence variant is associated with susceptibility to tuberculosis. Gene 515:229–232
Chaitanya VS, Jadhav RS, Lavania M, Singh M, Valluri V, Sengupta U (2014) Interleukin-17F single-nucleotide polymorphism (7488T %3e C) and its association with susceptibility to leprosy. Int J Immunogenet 41(2):131–137
Dai W, Zhou Q, Tan X, Sun C (2014) IL-17A (-197G/A) and IL-17F (7488T/C) gene polymorphisms and cancer risk in Asian population: a meta-analysis. Onco Targets Ther 7:703–711
Zhou B, Zhang P, Wang Y, Shi S, Zhang K, Liao H, Zhang L (2013) Interleukin-17 gene polymorphisms are associated with bladder cancer in a Chinese Han population. Mol Carcinog 52:871–878
Rangaraj A, Ye L, Sanders AJ, Price PE, Harding KG, Jiang WG (2017) Molecular and cellular impact of Psoriasin (S100A7) on the healing of human wounds. Exp Ther Med 13(5):2151–2160
Enerbäck C, Porter DA, Seth P, Sgroi D, Gaudet J, Weremowicz S, Morton CC, Schnitt S, Pitts RL, Stampl J, Barnhart K, Polyak K (2002) Psoriasin Expression in mammary epithelial cells in vitro and in vivo. Can Res 62(1):43–47
Anderson KS, Wong J, Polyak K, Aronzon D, Enerbäck C (2008) Detection of psoriasin/S100A7 in the sera of patients with psoriasis. Br J Dermatol 160(2):325–332
Ekman AK, Vegfors J, Eding CB, Enerbäck C (2017) Overexpression of Psoriasin (S100A7) Contributes to dysregulated differentiation in psoriasis. Acta Derm Venereol 97(4):441–448
Hegyi Z, Zwicker S, Bureik D, Peric M, Koglin S, Batycka-Baran A, Prinz JC et al (2012) Vitamin D analog calcipotriol suppresses the Th17 cytokine-induced proinflammatory S100 “alarmins” psoriasin (S100A7) and koebnerisin (S100A15) in psoriasis. J Invest Dermatol 132(5):1416–1424
Salama RH, Al-Shobaili HA, Al Robaee AA, Alzolibani AA (2013) Psoriasin: a novel marker linked obesity with psoriasis. Dis Mark 34(1):33–39
Kim YG, Kim EY, Ihm CG, Lee TW, Lee SH, Jeong KH, Moon JY et al (2012) Gene polymorphisms of interleukin-17 and interleukin-17 receptor are associated with end-stage kidney disease. Am J Nephrol 36(5):472–477
Park JS, Park BL, Kim MO, Heo JS, Jung JS, Bae DJ, Uh ST, Kim MK, Choi IS, Cho SH, Hong CS, Lee JY, Choi BW, Shin HD, Park CS (2013) Association of single nucleotide polymorphisms on Interleukin 17 receptor A (IL17RA) gene with aspirin hypersensitivity in asthmatics. Hum Immunol 74(5):598–606
Tarnowski M, Słuczanowska-Głabowska S, Pawlik A, Mazurek-Mochol M, Dembowska E (2017) Genetic factors in pathogenesis of diabetes mellitus after kidney transplantation. Ther Clin Risk Manag 13(3):439–446
Lee YC, Chung JH, Kim SK, Rhee SY, Chon S, Oh SJ, Hong IK, Eun YG (2014) Association between interleukin 17/interleukin 17 receptor gene polymorphisms and papillary thyroid cancer in Korean population. Cytokine 71(2):283–288
Awad SM, Attallah DA, Salama RH, Mahran AM (2018) Abu El-Hamed E Serum levels of psoriasin (S100A7) and koebnerisin (S100A15) as potential markers of atherosclerosis in patients with psoriasis. Clin Exp Dermatol 43(3):262–267
Rocha-Pereira P, Santos-Silva A, Rebelo I, Figueiredo A, Quintanilha A, Teixeira F (2001) Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease. Clin Chim Acta 303(1–2):33–39
de Oliveira PS, Cardoso PR, Lima EV, Pereira MC, Duarte AL, Pitta Ida R, Rêgo MJ, Pitta MG (2015) IL-17A, IL-22, IL-6, and IL-21 serum levels in plaque-type psoriasis in brazilian patients. Mediators Inflamm 2015:819149
Acknowledgements
Self-funding was applied from all authors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors stated that no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sabry, D., Aboraia, N. & Samir, M. A potential association between psoriasin to rs4819554 of IL-17RA gene polymorphism in psoriasis Egyptian patients. Arch Dermatol Res 312, 273–281 (2020). https://doi.org/10.1007/s00403-019-02011-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-019-02011-x